[Copy number variations in pediatric ETV6/RUNX1 positive acute lymphoblastic leukemia]

Yao Zou1, Li Zhang, Xiaoming Liu

  • 1Department of Pediatrics, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.

Insights

Copy number variations (CNVs) in pediatric ETV6/RUNX1 gene positive acute lymphoblastic leukemia (ALL) impact patient prognosis. Specific CNVs in EBF1, PAX5, and ETV6 genes significantly correlate with recurrence-free survival in these young patients.

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Genetics

Background:

  • Pediatric acute lymphoblastic leukemia (ALL) is a significant childhood cancer.
  • The ETV6/RUNX1 fusion gene is a common genetic alteration in pediatric ALL.
  • Understanding genetic variations like copy number variations (CNVs) is crucial for prognosis.

Purpose of the Study:

  • To investigate copy number variations (CNVs) in pediatric patients with ETV6/RUNX1 positive ALL.
  • To determine the correlation between these CNVs and clinical features.
  • To assess the prognostic relevance of CNVs in ETV6/RUNX1 positive ALL.

Main Methods:

  • Analysis of 141 pediatric patients (<14 years) diagnosed with ETV6/RUNX1 positive ALL.
  • Copy number variations (CNVs) were analyzed using multiplex ligation-dependent probe amplification (MLPA).
  • Survival rates (Overall Survival - OS, Event-Free Survival - EFS, Recurrence-Free Survival - RFS) were estimated using Kaplan-Meier and log-rank tests.

Main Results:

  • CNVs were detected in 76.8% of the 95 tested patients.
  • Frequent CNVs involved ETV6 (54.8%), PAX5 (21.1%), CDKN2A/2B (18.9%), EBF1 (15.8%), and BTG1 (10.5%).
  • Deletions and amplifications in EBF1, PAX5, and ETV6 showed statistically significant correlations with 5-year recurrence-free survival (RFS).

Conclusions:

  • Copy number variations (CNVs) are prevalent in pediatric ETV6/RUNX1 positive ALL.
  • Specific CNVs, particularly in ETV6, PAX5, and EBF1, have significant prognostic relevance.
  • CNV analysis can aid in predicting outcomes for children with ETV6/RUNX1 positive ALL.
Abstract